United Kingdom's drug regulator on Friday informed that it had approved the Covid-19 vaccine developed by Pfizer and BioNTech for use on 12 to 15 year-olds after similar clearances were given in the US and the EU.

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) today announced this decision following a "rigorous review" of the safety, and effectiveness of the vaccine in this age group.